Main problems for biotechnology development in Spain 2022
Published by
In 2022, more than half of the surveyed biotech companies and organizations in Spain stated that time and costs were the main challenges for biotechnology development. Access to capital and regulatory requirements followed on the list, representing the main problems for biotech development to around 41.8 percent and 41.3 percent of interviewed companies in the European country, respectively.
